Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S4 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1
  1. Home
  2. Publications
  3. Supplementary Figure S4 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Supplementary Figure S4 from Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2− Advanced Breast Cancer: Results from SERENA-1

Authors:
  • RBRichard D. Baird
    Richard D. Baird
  • BHBegoña Bermejo de Las Heras
    Begoña Bermejo de Las Heras
  • MRManuel Ruiz-Borrego
    Manuel Ruiz-Borrego
  • CVChristos Vaklavas
    Christos Vaklavas
  • IMIrene Moreno
    Irene Moreno
  • Mafalda Oliveira
    Mafalda Oliveira
  • AAAnne Armstrong
    Anne Armstrong
  • NTNicholas Turner
    Nicholas Turner
  • JIJason Incorvati
    Jason Incorvati
  • CTChris Twelves
    Chris Twelves
  • ECEva Ciruelos
    Eva Ciruelos
  • EHErika Hamilton
    Erika Hamilton

Open Access
Publisher website
Google Scholar
  • 15 October 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30363336
Abstract
ORR, CBR24, and median PFS for subgroup analysis across pooled camizestrant 75 mg combination arms
Keywords
  • BREAST CANCER
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • ENDOCRINE-RELATED CANCERS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.